Stephanie specialises in inbound investment into Indonesia, public and private M&A, and joint ventures. She advises local business groups and major foreign investors on their joint ventures, and growth companies and venture capital funds on fundraisings and corporate restructurings. She covers a broad range of sectors, with a particular focus on the healthcare sector.
Her clients include local business groups and conglomerates, blue chip multinationals, and international private equity firms. She is accustomed to dealing with international clients investing in Indonesia and providing legal advice to international standards.
Stephanie is recognised as a rising star in M&A by IFLR1000.
She has advised:
Healthcare
read more
Stephanie specialises in inbound investment into Indonesia, public and private M&A, and joint ventures. She advises local business groups and major foreign investors on their joint ventures, and growth companies and venture capital funds on fundraisings and corporate restructurings. She covers a broad range of sectors, with a particular focus on the healthcare sector.
Her clients include local business groups and conglomerates, blue chip multinationals, and international private equity firms. She is accustomed to dealing with international clients investing in Indonesia and providing legal advice to international standards.
Stephanie is recognised as a rising star in M&A by IFLR1000.
She has advised:
Healthcare
- Mayapada Healthcare Group, a listed healthcare group in Indonesia, in relation to a US$157 million investment hybrid investment by Bain Capital into Anugerahraya Sejahteraraya Tbk (SRAJ) involving both equity and bond subscription
- Columbia Asia on its acquisition from TE Asia Healthcare Partners of a healthcare group which operates specialty hospitals and clinics that provide oncology, cardiology, and orthopaedic services in Southeast Asia
- Northstar Ventures on its investment into Dachin Group, which operates a social e-commerce platform selling consumer products
- PT Omni Healthcare, an Indonesian hospital group, on the sale of its controlling stake in hospital operator PT Sarana Meditama Metropolitan Tbk to PT Elang Mahkota Teknologi Tbk (Emtek), one of Indonesia’s largest media and tech solutions companies, which has been expanding its portfolio to include healthcare operations
- Silk Road Fund, a state-owned investment fund of the Chinese government, on its proposed investment into Kimia Farma
- a private equity firm on a significant investment in a major Indonesian company group engaging in healthcare services, including hospitals, laboratories and clinics, structured through a combination of loans, options and convertible bonds
- Tunggal Group, a leading Indonesian pharmaceuticals group, on its sale in PT Aventis Pharma alongside Sanofi to PT Kalbe Farma Tbk
Consumer
- Kopi Kenangan, an Indonesian coffee shop chain, on its Series C fundraising, which made the group the first New Retail F&B Unicorn in Southeast Asia
- Sephora in relation to the potential restructuring of its distribution business model and partnership with a local partner in Indonesia
- Satu Dental, a healthcare group focusing on dental care with a chain of dental clinics and selling consumer products, on its Series A fundraising
- LinkAja, an SOE-backed digital payment platform, on a strategic investment by Grab, a Southeast Asia super app, in its Series B funding round, being the first investment by a major technology company in LinkAja
- KKR on its acquisition of Unilever’s margarine and spreads business in Indonesia as part of the US$8 billion global acquisition of Unilever’s margarine and spreads business, including Indonesian licencing, asset transfer and employment matters
Education
- Georgetown University on establishment of a foundation for the purpose of offering post-graduate studies in Indonesia
- Deakin University on establishment of an education institution in Bandung, Indonesia in collaboration with the University of Lancaster
Read less
